Cross-reactivity of steroid hormone immunoassays: Clinical significance and two-dimensional molecular similarity prediction

BMC Clinical Pathology

Volumn 14, Issue 1, 2014, Pages

  Krasowski, Matthew D ^a   Drees, Denny ^a   Morris, Cory S ^a   Maakestad, Jon ^a   Blau, John L ^a,b   Ekins, Sean ^c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Collaborations in Chemistry ^*  (United States)

Author keywords

Anabolic agents; Estradiol; Glucocorticoids; Immunoassays; Progesterone; Similarity; Testosterone

Indexed keywords

EID: 84904080304     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-14-33     Document Type: Article

References (71)

1. Measurement of glucocorticoids in biological fluids. Holder G, Methods Mol Biol 2006 324 141 157
2. Measurement of androgens. Wheeler MJ, Methods Mol Biol 2006 324 197 211
3. Principles of immunochemical techniques. Kricka LJ, Tietz textbook of clinical chemistry and molecular diagnostics St. Louis, MO: Elsevier Saunders, Burtis CA, Ashwood ER, Bruns DE, 4 2006 219 243
4. Principles and clinical applications of liquid chromatography-tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones. Kulle AE, Welzel M, Holterhus PM, Riepe FG, J Endocrinol Invest 2011 34 702 708
5. Steroid measurement with LC-MS/MS. Application examples in pediatrics. Rauh M, J Steroid Biochem Mol Biol 2010 121 520 527
6. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. Shackleton C, J Steroid Biochem Mol Biol 2010 121 481 490
7. Steroid hormone analysis by tandem mass spectrometry. Soldin SJ, Soldin OP, Clin Chem 2009 55 1061 1066
8. Interferences in hormone immunoassays. Klee GG, Clin Lab Med 2004 24 1 18 (Pubitemid 38638106)
9. Interferences in immunoassays-still a threat. Kricka LJ, Clin Chem 2000 46 1037 1038
10. Dehydroepiandrostenedione sulphate interferes in many direct immunoassays for testosterone. Middle JG, Ann Clin Biochem 2007 44 173 177
11. Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosterone. Warner MH, Kane JW, Atkin SL, Kilpatrick ES, Ann Clin Biochem 2006 43 196 199 (Pubitemid 43668151)
12. Interference of the antihormone RU486 in the determination of testosterone and estradiol by enzyme-immunoassay. Tejada F, Cremades A, Monserrat F, Penafiel R, Clin Chim Acta 1998 275 63 69 (Pubitemid 28274532)
13. Performance characteristics of five automated serum cortisol immunoassays. Roberts RF, Roberts WL, Clin Biochem 2004 37 489 493 (Pubitemid 38746643)
14. Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine. Krasowski MD, Pizon AF, Siam MG, Giannoutsos S, Iyer M, Ekins S, BMC Emerg Med 2009 9 5
15. Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays. Krasowski MD, Siam MG, Iyer M, Ekins S, Ther Drug Monit 2009 31 337 344
16. Chemoinformatic methods for predicting interference in drug of abuse/toxicology immunoassays. Krasowski MD, Siam MG, Iyer M, Pizon AF, Giannoutsos S, Ekins S, Clin Chem 2009 55 1203 1213
17. Cross-reactivity studies and predictive modeling of Bath Salts and other amphetamine-type stimulants with amphetamine screening immunoassays. Petrie M, Lynch KL, Ekins S, Chang JS, Goetz RJ, Wu AH, Krasowski MD, Clin Toxicol (Phila) 2013 51 83 91
18. Powers DM, Boyd JC, Glick MR, Interference testing in clinical chemistry (EP7-A) NCCLS: Villanova, PA 1986
19. Cortisol package insert for Elecsys 1010, Elecsys 2010, Modular Analytics E170, cobas e 411, and cobas e 601. 2008-04, V2 English Indianapolis, IN, USA: Roche Diagnostics
20. Methylprednisolone pharmacokinetics after intravenous and oral administration. Al-Habet SM, Rogers HJ, Br J Clin Pharmacol 1989 27 285 290 (Pubitemid 19097436)
21. Rapid liquid-chromatographic method for simultaneous determination of plasma prednisone, prednisolone, and cortisol in pediatric renal-transplant recipients. McBride JH, Rodgerson DO, Park SS, Reyes AF, Clin Chem 1991 37 643 646 (Pubitemid 21892701)
22. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE, J Clin Endocrinol Metab 2006 91 2179 2184 (Pubitemid 43855002)
23. Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration. Ribot M, Polito A, Grassin-Delyle S, Annane D, Alvarez JC, Clin Chim Acta 2013 420 109 113
24. Mayo Medical Laboratories (Rochester, MN). [ http://www. mayomedicallaboratories.com/ ]
25. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary- adrenal function. Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Muller B, J Clin Endocrinol Metab 2002 87 5470 5475 (Pubitemid 36034346)
26. Improved bioavailability and clinical response in patients with chronic liver disease following the administration of a spironolactone: beta-cyclodextrin complex. Abosehmah-Albidy AZ, York P, Wong V, Losowsky MS, Chrystyn H, Br J Clin Pharmacol 1997 44 35 39 (Pubitemid 27296793)
27. Simultaneous determination of spironolactone and its metabolites in human plasma. Jankowski A, Skorek-Jankowska A, Lamparczyk H, J Pharm Biomed Anal 1996 14 1359 1365 (Pubitemid 26235199)
28. Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples. Sandall JM, Millership JS, Collier PS, McElnay JC, J Chromatogr B Analyt Technol Biomed Life Sci 2006 839 36 44 (Pubitemid 44056042)
29. Pharmacokinetics and metabolism of formestane in breast cancer patients. Lonning PE, Geisler J, Johannessen DC, Gschwind HP, Waldmeier F, Schneider W, Galli B, Winkler T, Blum W, Kriemler HP, Miller WR, Faigle JW, J Steroid Biochem Mol Biol 2001 77 39 47 (Pubitemid 32455351)
30. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia. von Schnakenburg K, Bidlingmaier F, Knorr D, Eur J Pediatr 1980 133 259 267 (Pubitemid 10112727)
31. DHEA sulfate package insert for Elecsys 1010, Elecsys 2010, Modular Analytics E170, cobas e 411, and cobas e 601. 2009-03, V13 English Indianapolis, IN, USA: Roche Diagnostics
32. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Tagawa N, Tamanaka J, Fujinami A, Kobayashi Y, Takano T, Fukata S, Kuma K, Tada H, Amino N, Clin Chem 2000 46 523 528 (Pubitemid 30210723)
33. Pregnanolone isomers, pregnenolone and their polar conjugates around parturition. Klak J, Hill M, Parizek A, Havlikova H, Bicikova M, Hampl R, Fait T, Sulcova J, Pouzar V, Kancheva R, Starka L, Physiol Res 2003 52 211 221 (Pubitemid 36427824)
34. Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Kushnir MM, Rockwood AL, Roberts WL, Pattison EG, Owen WE, Bunker AM, Meikle AW, Clin Chem 2006 52 1559 1567 (Pubitemid 44148319)
35. Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects. Hill M, Lukac D, Lapcik O, Sulcova J, Hampl R, Pouzar V, Starka L, Clin Chem Lab Med 1999 37 439 447 (Pubitemid 29218965)
36. Serum adrenal steroid concentrations in premature infants. Lee MM, Rajagopalan L, Berg GJ, Moshang T Jr, J Clin Endocrinol Metab 1989 69 1133 1136 (Pubitemid 20010038)
37. Estradiol II package insert for Elecsys 1010, Elecsys 2010, Modular Analytics E170, cobas e 411, and cobas e 601. 2009-05, V15 English Indianapolis, IN, USA: Roche Diagnostics
38. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Abrams LS, Skee DM, Natarajan J, Wong FA, Anderson GD, Br J Clin Pharmacol 2002 53 141 146 (Pubitemid 34264268)
39. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C, Clin Pharmacol Ther 1999 65 428 438 (Pubitemid 29196547)
40. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB, Clin Pharmacol Ther 2004 75 464 475 (Pubitemid 38534567)
41. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. Trapnell CB, Donahue SR, Collins JM, Flockhart DA, Thacker D, Abernethy DR, Clin Pharmacol Ther 1998 64 597 602 (Pubitemid 29011379)
42. Correlation of serum hormone concentrations in maternal and umbilical cord samples. Troisi R, Potischman N, Roberts JM, Harger G, Markovic N, Cole B, Lykins D, Siiteri P, Hoover RN, Cancer Epidemiol Biomarkers Prev 2003 12 452 456 (Pubitemid 36578484)
43. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Wright JV, Schliesman B, Robinson L, Altern Med Rev 1999 4 266 270 (Pubitemid 29418313)
44. Progesterone II package insert for Elecsys 1010, Elecsys 2010, Modular Analytics E170, cobas e 411, and cobas e 601. 2009-05, V12 English Indianapolis, IN, USA: Roche Diagnostics
45. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Baghai TC, di Michele F, Schule C, Eser D, Zwanzger P, Pasini A, Romeo E, Rupprecht R, Neuropsychopharmacology 2005 30 1181 1186 (Pubitemid 40720977)
46. Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women. Ohtsu T, Fujii H, Wakita H, Igarashi T, Itoh K, Imoto S, Kohagura M, Sasaki Y, Cancer Chemother Pharmacol 1998 42 1 8 (Pubitemid 28224984)
47. Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men. Bagchus WM, Smeets JM, Verheul HA, De Jager-Van Der Veen SM, Port A, Geurts TB, J Clin Endocrinol Metab 2005 90 2624 2630 (Pubitemid 40686300)
48. Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. Evans TR, Di Salle E, Ornati G, Lassus M, Benedetti MS, Pianezzola E, Coombes RC, Cancer Res 1992 52 5933 5939
49. Testosterone II package insert for Elecsys 2010, Modular Analytics E170, cobas e 411, and cobas e 601. 2010-05, V1 English Indianapolis, IN, USA: Roche Diagnostics
50. Stable isotope methodology in the pharmacokinetic studies of androgenic steroids in humans. Shinohara Y, Baba S, Steroids 1990 55 170 176 (Pubitemid 20270441)
51. Pharmacokinetics of boldenone and stanozolol and the results of quantification of anabolic and androgenic steroids in race horses and nonrace horses. Soma LR, Uboh CE, Guan F, McDonnell S, Pack J, J Vet Pharmacol Ther 2007 30 101 108 (Pubitemid 46365033)
52. Molecular similarity: a key technique in molecular informatics. Bender A, Glen RC, Org Biomol Chem 2004 2 3204 3218
53. In silico pharmacology for drug discovery: applications to targets and beyond. Ekins S, Mestres J, Testa B, Br J Pharmacol 2007 152 21 37 (Pubitemid 47339897)
54. Virtual screening in drug discovery-a computational perspective. Reddy AS, Pati SP, Kumar PP, Pradeep HN, Sastry GN, Curr Protein Pept Sci 2007 8 329 351 (Pubitemid 47317040)
55. Detecting the administration of endogenous anabolic androgenic steroids. Ayotte C, Handb Exp Pharmacol 2010 77 98
56. Preliminary study for simultaneous detection and quantification of androgenic anabolic steroids using ELISA and pattern recognition techniques. Calvo D, Tort N, Salvador JP, Marco MP, Centi F, Marco S, Analyst 2011 136 4045 4052
57. Biochemistry and physiology of anabolic androgenic steroids doping. Lippi G, Franchini M, Banfi G, Mini Rev Med Chem 2011 11 362 373
58. Comparison of progesterone concentration determination by 12 non-isotopic immunoassays and gas chromatography/mass spectrometry in 99 human serum samples. Boudou P, Taieb J, Mathian B, Badonnel Y, Lacroix I, Mathieu E, Millot F, Queyrel N, Somma-Delpero C, Patricot MC, J Steroid Biochem Mol Biol 2001 78 97 104 (Pubitemid 32786792)
59. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Forti G, Wu FC, Eur J Endocrinol 2012 166 983 991
60. Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Moal V, Mathieu E, Reynier P, Malthiery Y, Gallois Y, Clin Chim Acta 2007 386 12 19 (Pubitemid 47417956)
61. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11beta-hydroxylase inhibitor metyrapone. Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D, Ann Clin Biochem 2011 48 441 446
62. Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men. Ohlsson C, Nilsson ME, Tivesten A, Ryberg H, Mellstrom D, Karlsson MK, Ljunggren O, Labrie F, Orwoll ES, Lee DM, Pye SR, O'Neill TW, Finn JD, Adams JE, Ward KA, Boonen S, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Vanderschueren D, Wu FC, Vandenput L, J Clin Endocrinol Metab 2013 98 1097 E1102
63. Advantages and challenges of mass spectrometry assays for steroid hormones. Stanczyk FZ, Clarke NJ, J Steroid Biochem Mol Biol 2010 121 491 495
64. Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect. Sluss PM, Hayes FJ, Adams JM, Barnes W, Williams G, Frost S, Ramp J, Pacenti D, Lehotay DC, George S, Ramsay C, Doss RC, Crowley WF, Jr, Clin Chim Acta 2008 388 99 105 (Pubitemid 350266580)
65. Performance characteristics of eight estradiol immunoassays. Yang DT, Owen WE, Ramsay CS, Xie H, Roberts WL, Am J Clin Pathol 2004 122 332 337 (Pubitemid 39145537)
66. Immunoassay of estradiol: unanticipated suppression by unconjugated estriol. Cao Z, Swift TA, West CA, Rosano TG, Rej R, Clin Chem 2004 50 160 165 (Pubitemid 38125713)
67. Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. Monnet C, Bettsworth F, Stura EA, Le Du MH, Menez R, Derrien L, Zinn-Justin S, Gilquin B, Sibai G, Battail-Poirot N, Jolivet M, Menez A, Arnaud M, Ducancel F, Charbonnier JB, J Mol Biol 2002 315 699 712 (Pubitemid 34729320)
68. Specificity improvement of a recombinant anti-testosterone Fab fragment by CDRIII mutagenesis and phage display selection. Hemminki A, Niemi S, Hoffren AM, Hakalahti L, Soderlund H, Takkinen K, Protein Eng 1998 11 311 319 (Pubitemid 28263845)
69. Crystal structure of an in vitro affinity- and specificity-matured anti-testosterone Fab in complex with testosterone. Improved affinity results from small structural changes within the variable domains. Valjakka J, Hemminki A, Niemi S, Soderlund H, Takkinen K, Rouvinen J, J Biol Chem 2002 277 44021 44027 (Pubitemid 36157828)
70. Structural insights into steroid hormone binding: the crystal structure of a recombinant anti-testosterone Fab fragment in free and testosterone-bound forms. Valjakka J, Takkinenz K, Teerinen T, Soderlund H, Rouvinen J, J Biol Chem 2002 277 4183 4190 (Pubitemid 34968680)
71. The importance of discerning shape in molecular pharmacology. Kortagere S, Krasowski MD, Ekins S, Trends Pharmacol Sci 2009 30 138 147